ArticleTuberculosis and respiratory diseases2024

Immune Checkpoint Inhibitor Score Predicts Survival Benefit of Immunotherapy in Patients with Non-small Cell Lung Cancer.

Da Hyun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.